FI954775A - Nya polycykliska föreningar och derivat därav som ämnen vilka främjar frigörelsen av neurotransmitters och vilka är användbara vid behandling av kognitiva rubbningar - Google Patents
Nya polycykliska föreningar och derivat därav som ämnen vilka främjar frigörelsen av neurotransmitters och vilka är användbara vid behandling av kognitiva rubbningar Download PDFInfo
- Publication number
- FI954775A FI954775A FI954775A FI954775A FI954775A FI 954775 A FI954775 A FI 954775A FI 954775 A FI954775 A FI 954775A FI 954775 A FI954775 A FI 954775A FI 954775 A FI954775 A FI 954775A
- Authority
- FI
- Finland
- Prior art keywords
- derivatives
- treatment
- cognitive disorders
- neurotransmitter release
- polycyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4401293A | 1993-04-08 | 1993-04-08 | |
US08/216,881 US5594001A (en) | 1993-04-08 | 1994-03-28 | Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders |
PCT/US1994/003673 WO1994024131A1 (en) | 1993-04-08 | 1994-04-04 | Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954775A0 FI954775A0 (sv) | 1995-10-06 |
FI954775A true FI954775A (sv) | 1995-10-06 |
Family
ID=26721086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954775A FI954775A (sv) | 1993-04-08 | 1995-10-06 | Nya polycykliska föreningar och derivat därav som ämnen vilka främjar frigörelsen av neurotransmitters och vilka är användbara vid behandling av kognitiva rubbningar |
Country Status (21)
Country | Link |
---|---|
US (1) | US5990132A (sv) |
EP (1) | EP0693069A1 (sv) |
JP (1) | JPH08509713A (sv) |
CN (2) | CN1058495C (sv) |
AU (1) | AU690906B2 (sv) |
BR (1) | BR9405954A (sv) |
CA (1) | CA2160112A1 (sv) |
CZ (1) | CZ251995A3 (sv) |
FI (1) | FI954775A (sv) |
HU (1) | HUT74104A (sv) |
IL (1) | IL109237A (sv) |
LV (1) | LV11179B (sv) |
NO (1) | NO308745B1 (sv) |
NZ (1) | NZ265183A (sv) |
OA (1) | OA10235A (sv) |
PL (1) | PL178570B1 (sv) |
RO (1) | RO115162B1 (sv) |
RU (1) | RU2152944C1 (sv) |
SI (1) | SI9420022A (sv) |
SK (1) | SK124695A3 (sv) |
WO (1) | WO1994024131A1 (sv) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750528A (en) * | 1995-02-01 | 1998-05-12 | The Dupont Merck Pharmaceutical Company | Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease |
US6262081B1 (en) | 1998-07-10 | 2001-07-17 | Dupont Pharmaceuticals Company | Composition for and method of treating neurological disorders |
JP5581607B2 (ja) | 2008-06-05 | 2014-09-03 | 住友化学株式会社 | 高分子化合物及びそれを用いた有機トランジスタ |
RS58700B1 (sr) | 2012-10-12 | 2019-06-28 | Broad Inst Inc | Gsk3 inhibitori i postupci njihove primene |
WO2014084612A1 (ko) * | 2012-11-30 | 2014-06-05 | 주식회사 엘지화학 | 신규한 화합물 및 이를 이용한 유기 전자 소자 |
WO2015027021A1 (en) | 2013-08-22 | 2015-02-26 | Bristol-Myers Squibb Company | Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
WO2015027015A1 (en) | 2013-08-22 | 2015-02-26 | Bristol-Myers Squibb Company | Imidazole-derived modulators of the glucocorticoid receptor |
CN106029614B (zh) | 2014-02-05 | 2019-05-31 | Vm肿瘤药物有限责任公司 | 化合物的组合物及其用途 |
GB201417369D0 (en) * | 2014-10-01 | 2014-11-12 | Redx Pharma Ltd | Compounds |
JP7097623B2 (ja) * | 2016-11-07 | 2022-07-08 | ヴァンダービルト ユニヴァーシティ | ムスカリン性アセチルコリンレセプターm4のポジティブアロステリック調節因子 |
WO2018187630A1 (en) | 2017-04-05 | 2018-10-11 | The Broad Institute, Inc. | Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1052346A (sv) * | 1964-09-09 | |||
US5173489A (en) * | 1986-04-10 | 1992-12-22 | The Dupont Merck Pharmaceutical Co. | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
WO1992021660A1 (en) * | 1991-05-29 | 1992-12-10 | Pfizer, Inc. | Tricyclic polyhydroxylic tyrosine kinase inhibitors |
DE69218795T2 (de) * | 1992-01-16 | 1997-07-10 | Du Pont Merck Pharma | Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen |
US5272269A (en) * | 1992-01-16 | 1993-12-21 | The Du Pont Merck Pharmaceutical Company | Disubstituted polycyclic systems and preparative methods therefor |
RU2051151C1 (ru) * | 1992-01-16 | 1995-12-27 | Дзе Дюпон Мерк Фармасьютикал Компани | Азотсодержащие гетероциклические производные флуорена |
US5185447A (en) * | 1992-01-29 | 1993-02-09 | Du Pont Merck Pharmaceutical Company | Polycyclic ketones and preparative methods therefor |
US5359070A (en) * | 1993-02-11 | 1994-10-25 | The Du Pont Merck Pharmaceutical Company | Unsymmetrical bis-imides as anticancer agents |
-
1994
- 1994-04-04 WO PCT/US1994/003673 patent/WO1994024131A1/en not_active Application Discontinuation
- 1994-04-04 CA CA002160112A patent/CA2160112A1/en not_active Abandoned
- 1994-04-04 BR BR9405954A patent/BR9405954A/pt not_active Application Discontinuation
- 1994-04-04 EP EP94913355A patent/EP0693069A1/en not_active Withdrawn
- 1994-04-04 HU HU9502929A patent/HUT74104A/hu unknown
- 1994-04-04 CZ CZ952519A patent/CZ251995A3/cs unknown
- 1994-04-04 JP JP6523257A patent/JPH08509713A/ja active Pending
- 1994-04-04 NZ NZ265183A patent/NZ265183A/en unknown
- 1994-04-04 SI SI9420022A patent/SI9420022A/sl unknown
- 1994-04-04 RU RU95120594/04A patent/RU2152944C1/ru active
- 1994-04-04 PL PL94310997A patent/PL178570B1/pl unknown
- 1994-04-04 SK SK1246-95A patent/SK124695A3/sk unknown
- 1994-04-04 RO RO95-01753A patent/RO115162B1/ro unknown
- 1994-04-04 AU AU65549/94A patent/AU690906B2/en not_active Ceased
- 1994-04-04 CN CN94191713A patent/CN1058495C/zh not_active Expired - Fee Related
- 1994-04-06 IL IL109237A patent/IL109237A/en not_active IP Right Cessation
-
1995
- 1995-10-06 FI FI954775A patent/FI954775A/sv unknown
- 1995-10-06 NO NO953989A patent/NO308745B1/no not_active IP Right Cessation
- 1995-10-06 OA OA60720A patent/OA10235A/en unknown
- 1995-10-09 LV LVP-95-302A patent/LV11179B/en unknown
-
1996
- 1996-06-17 US US08/664,631 patent/US5990132A/en not_active Expired - Fee Related
-
2000
- 2000-01-08 CN CN00100940A patent/CN1295072A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
NO308745B1 (no) | 2000-10-23 |
LV11179B (en) | 1997-06-20 |
CN1295072A (zh) | 2001-05-16 |
IL109237A (en) | 1998-02-08 |
RO115162B1 (ro) | 1999-11-30 |
US5990132A (en) | 1999-11-23 |
NZ265183A (en) | 1997-11-24 |
BR9405954A (pt) | 1995-12-26 |
NO953989L (no) | 1995-12-07 |
HUT74104A (en) | 1996-11-28 |
IL109237A0 (en) | 1994-07-31 |
CN1058495C (zh) | 2000-11-15 |
HU9502929D0 (en) | 1995-11-28 |
EP0693069A1 (en) | 1996-01-24 |
PL310997A1 (en) | 1996-01-22 |
CA2160112A1 (en) | 1994-10-27 |
LV11179A (lv) | 1996-04-20 |
AU6554994A (en) | 1994-11-08 |
CZ251995A3 (en) | 1996-01-17 |
OA10235A (en) | 1997-10-07 |
JPH08509713A (ja) | 1996-10-15 |
PL178570B1 (pl) | 2000-05-31 |
FI954775A0 (sv) | 1995-10-06 |
CN1122135A (zh) | 1996-05-08 |
NO953989D0 (no) | 1995-10-06 |
SK124695A3 (en) | 1996-06-05 |
WO1994024131A1 (en) | 1994-10-27 |
RU2152944C1 (ru) | 2000-07-20 |
SI9420022A (en) | 1996-10-31 |
AU690906B2 (en) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE243694T1 (de) | 4-mercaptoacetylamino-(2)benzazepinon(3)- derivate, und verwendung als enkephalinase- inhibitoren | |
DE69432569D1 (de) | Synthese von Taxol und deren Derivate | |
DE69606028D1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung | |
ATA188592A (de) | Alkyl-bisacylphosphinoxide, diese enthaltende zusammensetzungen und ihre verwendung | |
MX9102582A (es) | Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
FI950697A (sv) | Nya användningar av IL-4 och IL-10 och antikroppar mot dem | |
DE69323714D1 (de) | Markierungszusammensetzung, deren Herstellung und Markierungsverfahren | |
EE9800302A (et) | Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat | |
FI954775A (sv) | Nya polycykliska föreningar och derivat därav som ämnen vilka främjar frigörelsen av neurotransmitters och vilka är användbara vid behandling av kognitiva rubbningar | |
ZA942444B (en) | Polycyclic systems and derivatives thereof as neurotransmitter release enhancers useful in the treatment of cognitive disorders | |
DE59608723D1 (de) | Polycyclische Iminooxadiazindione, deren Herstellung und Verwendung | |
FI960867A (sv) | Bensazepinderivat, dess farmaceutisk blandning och mellanprodukt | |
BR9206741A (pt) | Composição fluoroquímica artigo e processo de preparação da composição fluoroquímica | |
EE03193B1 (et) | (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks | |
BR9400338A (pt) | Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano | |
DE69422126D1 (de) | Flüssigkristallzusammensetzung, Flüssigkristallvorrichtung und diese verwendende Vorrichtung | |
BR8803768A (pt) | Composicao odorante,processo para producao de compostos e uso dos ditos compostos | |
MX9301935A (es) | Compuestos para el tratamiento de alteraciones neurodegenerativas. | |
IT9067363A0 (it) | Composti polifluoroalchilici azotati, procedimento per la loro preparazione e loro impiego | |
DE69623819D1 (de) | Furan- und thiophencarbothioamid derivate, deren herstellung und deren verwendung als inhibitoren der replikation von hiv-1 und hiv-1 mutanten | |
FI942046A0 (sv) | Polycykliska föreningar och förfarande för deras framställning | |
BR9202709A (pt) | Composicao,processo para aperfeicoar as propriedades de uso de lubrificantes e compostos | |
FI933548A0 (fi) | Produktion av slagg med hoeg titandioxidhalt ur ilmenit | |
BR9508529A (pt) | Produto compósito composiçao processo e uso de uma composiçao oxidante | |
BR9205493A (pt) | Composicao farmaceutica e processo para fabricacao de composicao farmaceutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Name/ company changed in application |
Owner name: DUPONT PHARMACEUTICALS COMPANY |